Reverb Therapeutics engages in the development of treatments for cancer and other diseases.
Reverb Therapeutics has raised $12.0M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
Reverb Therapeutics's investors include Amplitude Venture Capital, KdT Ventures, InBC Investment, Myeloma Investment Fund, Finchley Healthcare Ventures.
Reverb Therapeutics is headquartered in Vancouver, Canada.
Reverb Therapeutics engages in the development of treatments for cancer and other diseases.
Reverb Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reverb Therapeutics — Funding & Investors." VCBacked, February 19, 2025, https://www.vcbacked.co/company/reverb-therapeutics. Accessed August 13, 2026.
VCBacked. (2025). Reverb Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/reverb-therapeutics
{{cite web |title=Reverb Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/reverb-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated